Allo-HSCT Might Improve Long-Term Survival in Patients with CD56-Positive AML
Journal of Blood Medicine · 2026-08 · Volume 17 · 1-12
DOI: 10.2147/jbm.s602123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Blood Medicine, 2026-08. Verfasst von Xiaotong Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221002, People's Republic of China.
ORCID-Profile: Xiaotong Zhu, Wei Chen, Depeng Li
Zitieren
APA
Zhu, X., Sun, Y., Chen, Y., Dhurel, R. S., Zhang, C., Xie, Y., Ni, M., Chen, W., Zhang, H., Wu, Q., Li, D., Pan, B., & Yan, Z. (2026). Allo-HSCT Might Improve Long-Term Survival in Patients with CD56-Positive AML. Journal of Blood Medicine, Volume 17, 1-12. https://doi.org/10.2147/jbm.s602123
Vancouver
Zhu X, Sun Y, Chen Y, Dhurel RS, Zhang C, Xie Y, et al. Allo-HSCT Might Improve Long-Term Survival in Patients with CD56-Positive AML. Journal of Blood Medicine. 2026;Volume 17:1-12. doi:10.2147/jbm.s602123
BibTeX
@article{Zhu2026,
author = {Zhu, Xiaotong and Sun, Yuting and Chen, Yanyan and Dhurel, Raj Singh and Zhang, Chen and Xie, Yutong and Ni, Man and Chen, Wei and Zhang, Huanxin and Wu, Qingyun and Li, Depeng and Pan, Bin and Yan, Zhiling},
title = {Allo-HSCT Might Improve Long-Term Survival in Patients with CD56-Positive AML},
journal = {Journal of Blood Medicine},
year = {2026},
volume = {Volume 17},
pages = {1--12},
doi = {10.2147/jbm.s602123}
}
EUVIMED